Panama Investigates CK Hutchison’s Port Unit After Court Voids Canal Contracts 
AWS Data Center in UAE Hit by Fire After Objects Strike Facility Amid Regional Tensions 
Asian Stocks Tumble as US-Iran Conflict Escalates and Oil Prices Surge 
Trump Warns Iran as Gulf Conflict Disrupts Oil Markets and Global Trade 
Boeing Secures $166.8 Million U.S. Navy Contract for P-8A Engineering and Software Support 
U.S. Stocks Close Lower as Hot PPI Data, Nvidia Slide Weigh on Wall Street 
Argentina Tax Reform 2026: President Javier Milei Pushes Lower Taxes and Structural Changes 
OpenAI Secures $110 Billion Funding Round at $840 Billion Valuation Ahead of IPO 
Netflix Stock Jumps 14% After Exiting Warner Bros Deal as Paramount Seals $110 Billion Acquisition 
Australia Housing Market Hits Record High Despite RBA Rate Hike 
Stock Market Movers: Dell, Block, Duolingo, Zscaler, CoreWeave, Autodesk, Rocket, MARA 
Samsung Electronics Stock Poised for $1 Trillion Valuation Amid AI and Memory Boom 
PBOC Scraps Forex Risk Reserve as Yuan Rally Pressures Chinese Exporters 
OpenAI Pentagon AI Contract Adds Safeguards Amid Anthropic Dispute 
Strait of Hormuz Oil and LNG Shipments Disrupted After U.S.-Israel Strikes on Iran 
Hyundai Motor Group to Invest $6.26 Billion in AI Data Center, Robotics and Renewable Energy Projects in South Korea 
MOEX Russia Index Hits 3-Month High as Energy Stocks Lead Gains 
Celltrion revealed on Thursday, Sept. 23, that it would be supplying its rapid COVID-19 test kit called DiaTrust to the US government. This happened after the nation’s Department of Defense awarded the contract to them.
The South Korean biopharma stated that starting October 1st, its American division, Celltrion USA, will begin delivering the DiaTrust rapid test kits to 25,000 locations. The sites include nursing homes, coronavirus testing centers, and military facilities.
According to The Korea Herald, based on the agreement signed by Celltrion and the US Defense Logistics Agency, the United States could purchase additional kits if necessary. For the initial supply, the amount of the contract is said to be $626.61 million or 738.2 billion in Korean won.
Details for the initial order, like how many would be delivered was not disclosed. However, the publication stated that Bloomberg mentioned that the deal was for a total of 19 million DiaTrust test kits. With its contract with the DOD, Celltrion became the US’ largest supplier of rapid COVID-19 test kits.
“The fact that we were awarded a procurement contract by the DLA after having passed its strict screen process is a recognition of Celltrion’s technology and supply capability,” Celltrion USA chief executive officer, Bonjoong Kim, said in a press release. “With the COVID-19 pandemic still not showing signs of waning, we plan to focus on executing this contract as diligently as possible and further solidify the external credibility of Celltrion’s diagnostic test kits portfolio.”
It was added that the DiaTrust kits that will be delivered through this deal are point-of-care tests (POCT). This means that the COVID-19 rapid test will only be used in the presence of medical professionals. Apparently, this is for safety and to ensure that the process is done properly for more accurate results.
As per Pulse News, DiaTrust was jointly developed by Celltrion and Humasis, a Korean R&D company. The test kit was authorized by the US Food and Drug Administration (FDA) for emergency use last April.
Finally, Celltrion’s DiaTrust rapid COVID-19 kit is an antigen test that is used in medical settings. It can reveal the results on the spot since it only takes as little as 15 minutes to complete.
